Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2002-01-22
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of vinorelbine combined with docetaxel in
treating women who have metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Medstar Health Research Institute Washington Hospital Center